Skip to content
ClinCalc Pro
Menu
Vitamin B12 — Megaloblastic Anaemia

Hydroxocobalamin

Brand names: Cobalin-H, Neo-Cytamen, Cyanokit (cyanide antidote)

Used in: Anaemia

Hydroxocobalamin is a form of vitamin B12 given by intramuscular injection to treat and prevent vitamin B12 deficiency, including pernicious anaemia and deficiency due to malabsorption.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is converted to the active coenzymes methylcobalamin and adenosylcobalamin, which are required for methionine synthesis and methylmalonyl-CoA metabolism, supporting DNA synthesis, normal erythropoiesis and myelin integrity.

Prescribing in practice

  • In severe deficiency, starting treatment can precipitate hypokalaemia as erythropoiesis resumes, so potassium should be considered during the initial response.
  • Hydroxocobalamin is preferred over cyanocobalamin in the UK because its longer retention allows less frequent maintenance injections.
  • Neurological involvement requires prompt and adequate replacement, and the cause of deficiency should be established as parenteral therapy is usually lifelong in malabsorption.

Monitoring

Monitor the haematological response and, in severe cases, serum potassium during early treatment, with periodic review of ongoing maintenance need.

Counselling the patient

  • Vitamin B12 is given as a course of injections and then usually maintained for life when due to absorption problems.
  • Tell your clinician about any numbness, tingling or balance problems.
  • Keep maintenance injection appointments to prevent the deficiency returning.

Evidence & guidelines

Hydroxocobalamin is the standard UK parenteral vitamin B12 preparation for pernicious anaemia and B12-deficiency states, reflecting its favourable retention compared with cyanocobalamin.

Reference: BCSH Guidelines B12 and Folate Deficiency (2014); BSH (2021); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.